Latest market price
119.33
+2.41+2.06%
OverviewShort InterestFilings
PPHVanEck Pharmaceutical ETF·NASDAQ
119.33+2.06%
TA
Loading chart...
Screen all →
VXUS-1.53%$82.37VUG-3.00%$85.06VTV-0.38%$228.02VO-0.95%$81.46VGT-4.32%$116.96VB-1.58%$290.05VWO-1.93%$55.51VIG-0.56%$247.76
Fund Snapshot
Category—Asset TypeEquityTagshealthcareReturn% 1Y30.66%Total Holdings26Perf Week3.83%
SponsorVanEckETF TypeTagssectorReturn% 3Y17.92%AUM$1.07BPerf Month10.35%
Fund FamilyBond TypeTags—Return% 5Y11.82%NAV/shPerf Quarter9.85%
Index—Average MaturityTags—Return% 10Y52W High120.86 -1.27%Perf Half Y16.62%
Index WeightingCommodity TypeTags—Return% SI52W Low91.04 31.07%Perf YTD15.66%
Active/PassiveQuant TypeTags—Flows% 1M6.35%Volatility1.56% 1.51%Perf Year31.18%
Dividend TTM2.14 (1.79%)ESG TypeTags—Flows% 3M61.07%ATR (14)2.15Perf 3Y53.54%
Dividend Ex-DateOct 01, 2026Dividend TypeSector/ThemeFlows% YTD66.55%RSI (14)68.01Perf 5Y59.98%
Dividend Gr. 3/5Y—Structure TypeRegionFlows% 1YBeta0.43Perf 10Y114.97%
Expense0.36%Growth/ValueSMA205.47%Flows% 3YRel Volume3.98Prev Close116.92
Inverse/LeveragedMarket CapSMA505.99%Flows% 5YAvg Volume320.65KPrice119.33
IPO DateDec 20, 2011Option/ShortYes / YesSMA20010.58%52W Range %95%Volume1,276,660Change2.06%
Assets Under Management
00.30B0.60B0.90B1.20BAprJunAugOct'25MarMayJulSepNov'26MarMayJulSep
● Assets Under Management
Latest News· Times ET
Oct-30-26
Oct-30-2610:09AM
Can GLP-1s Fatten Your Portfolio? We Examine the VanEck Pharmaceutical ETF vs State Street SPDR Pharmaceuticals ETFfool.com
Oct-29-26
Oct-29-2601:20AM
PPH: Key Pharmaceutical Innovations Support Bullish Outlook (Upgrade)seekingalpha.com
Oct-26-26
Oct-26-2611:40AM
Which Pharmaceutical ETF Is the Better Buy: iShares’ Domestic IHE or VanEck’s Global PPH?fool.com
02:02AM
CIO Weekly: 3 Tests To The Equities RallySeekingAlpha
Oct-11-26
Oct-11-2606:17PM
Which Healthcare ETF Is the Better Buy: Simplify's Active PINK or VanEck's Pharma-Focused PPH?fool.com
Oct-07-26
Oct-07-2609:10AM
Market Concentration: Building For More Than One OutcomeSeekingAlpha
Oct-06-26
Oct-06-2611:26AM
Execution of Pharma Tariffs Brings These ETFs Into Focuszacks.com
Oct-05-26
Oct-05-2607:20AM
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?zacks.com
Oct-02-26
Oct-02-2608:13PM
Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJPfool.com
Sep-26-26
Sep-26-2607:37AM
David Rubenstein, Co-Founder Of The Carlyle Group, On The Business Of Sports, Investing And LeadershipSeekingAlpha
Sep-18-26
Sep-18-2602:18AM
'Anthropic quietly sets up biology lab as it ramps AI drug program' - Reuters ExclusiveBenzinga
Sep-15-26
Sep-15-2606:44PM
VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits?fool.com
Sep-11-26
Sep-11-2607:17AM
Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs.fool.com
Sep-07-26
Sep-07-2611:15AM
Here's How Trump's Drug Deals Are Likely to Impact Healthcare ETFsYahoo
Sep-03-26
Sep-03-2608:05AM
The Market May Be Telling Us We're Entering A Capital Formation CycleSeekingAlpha
Fund

VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Ownership

Per-holder 13F data isn't yet ingested for ETFs — coming with the next data layer expansion.

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR